Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 920-923

  Koyano, Shin ^a   Suzutani, Tatsuo ^a   Yoshida, Itsurou ^a   Azuma, Masanobu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GANCICLOVIR; LOBUCAVIR; NUCLEOSIDE; OXETANOCIN G; SORIVUDINE; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION;

EID: 0029928614     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.920     Document Type: Article

References (24)

1. Biron, K. K., and G. B. Elion. 1980. In vitro susceptibility of varicella-zoster viras to acyelovir. Antimicrob. Agents Chemother. 18:443-447.
2. Burns, W. H., R. Saral, G. W. Santos, O. L. Laskin, P. S. Lietman, C. McLaren, and D. W. Barry. 1982. Isolation and characterisation of resistant herpes simplex virus after acyclovir therapy. Lancet i:421-423.
3. Chatis, P. A., and C. S. Crumpacker. 1992. Resistance of herpesviruses to antiviral drugs. Antimicrob. Agents Chemother. 36:1589-1595.
4. Chee, M, S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1151-1160.
5. Cheng, Y.-C., E.-S. Huang, J.-C. Lin, E.-C. Mar, J. S. Pagano, G. E. Dutschman, and S. P. Grill. 1983 Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 80:2767-2770.
6. Elion, G. B., P. A. Furman, J. A. Fyfe, P. D. Miranda, L. Beauchamp, and H. J. Schaeffer. 1977. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Natl. Acad. Sci. USA 74:5716-5720.
7. Fyfe, J. A., P. M. Keller, P. A. Furman, R. L. Miller, and G. B. Elion. 1978. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol. Chem. 253:8721-8727.
8. Grose, C., D. M. Perrotta, P. A. Brunell, and G. C. Smith. 1979. Cell-free varicella-zoster virus in cultured human melanoma cells J. Gen. Virol. 43: 15-27.
9. Keller, P. M., S. A. McKee, and J. A. Fyfe. 1985. Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation. J. Biol. Chem. 260:8664-8667
10. Lacey, S. F., T. Suzutani, K. L. Powell, D. J. M. Purifoy, and R. W. Honess. 1991. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J. Gen. Virol. 72:623-630.
11. Littler, E., A, D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature (London) 358:160-162.
12. Ng, T. I., and C. Grose. 1992. Serine protein kinase associated with varicella-zoster virus ORF47. Virology 191:9-18.
13. Ng, T. I., L. Keenan, P. R. Kinchington, and C. Grose. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol 68:1350-1359
14. Ono, K., H. Nakane, and E. DeClercq. 1990. Potent inhibitory effects of the 5′-triphosphates of (E)-5-(2-bromovinyl)-2′-deoxyuridine and (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil on DNA polymerase. Eur. J Biochem. 190:463-467.
15. Sakuma, T. 1984. Strains of varicella-zoster virus resistant to 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Antimicrob. Agents Chemother. 25:742-746.
16. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (London) 358:162-164.
17. Suzutani, T., L. C. Davies, and R. W. Honess. 1993. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase. J. Gen. Virol. 74:1011-1016.
18. Suzutani, T., S. Koyano, M. Takada, I. Yoshida, and M. Azuma. 1995. Analysis of the relationship between cellular thymidine kinase activity and virulence of thymidine kinase-negative herpes simplex virus types 1 and 2. Microbiol. Immunol. 39:787-794.
19. Suzutani, T., S. F. Lacey, K. L. Powell, D. J. M. Purifoy, and R. W. Honess. 1992. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. J. Virol. 66:2118-2124.
20. Suzutani, T., H. Machida, and T. Sakuma. 1988. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells Antimicrob. Agents Chemother. 32: 1046-1052.
21. Suzutani, T., H. Machida, T. Sakuma, and M. Azuma. 1988. Effects of various nucleosides on antiviral activity and metabolism of 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother. 32:1547-1551.
22. Wade, J. C., C. McLaren, and J. D. Meyers. 1983. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J. Infect. Dis. 148:1077-1082.
23. Yokota, T., K. Konno, S. Mori, S. Sigeta, M. Kumagai, Y. Watanabe, and H. Machida. 1989. Mechanism of selective inhibition of varicella zoster virus replication by 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Mol. Pharmacol. 36:312-316.
24. Zhang, H., R. Scholl, J. Browse, and C. Somerville. 1988. Double stranded DNA sequencing as a choice for DNA sequencing. Nucleic Acids Res. 16:1220.